摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one | 675130-46-8

中文名称
——
中文别名
——
英文名称
(5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one
英文别名
(1aR,3R,7aR,7bS)-3-ethylperhydro[1,3]oxazolo[3,4-a]oxireno[2,3-c]pyridin-5-one;(1R,2S,4R,6R)-6-ethyl-3,9-dioxa-7-azatricyclo[5.3.0.02,4]decan-8-one
(5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one化学式
CAS
675130-46-8
化学式
C9H13NO3
mdl
——
分子量
183.207
InChiKey
YJUUHAVIFGFIDW-XUTVFYLZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    42.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-onesodium hydroxide 、 sodium hydride 、 溶剂黄146 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 48.5h, 生成 ((2R,3S,4S,6R)-3,4-Bis-benzyloxy-6-ethyl-piperidin-2-yl)-methanol
    参考文献:
    名称:
    1 - O -β-d-Glucopyranosyl-5-deoxyadenophorine及其糖苷配子同源物的首次全合成:绝对构型的确定
    摘要:
    有效的糖苷酶抑制剂1- O - β - d-吡喃葡萄糖基-5-脱氧腺苷及其配子同源物的第一个总合成分别由(R)-加纳醛。该合成利用了几个关键反应,包括手性亚胺的非对映选择性烯丙基化,立体选择性环氧化和糖苷偶联。此外,这项研究明确地确定了天然产物的绝对构型。
    DOI:
    10.1021/jo035522m
  • 作为产物:
    描述:
    (5R,8aS)-5-ethyl-4,5,6,8a-tetrahydrooxazolidino[3,4-a]pyridin-3-one二甲基二环氧乙烷 作用下, 以 丙酮 为溶剂, 反应 4.0h, 以60%的产率得到(5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one
    参考文献:
    名称:
    (+)-腺嘌呤的首次全合成,一种天然存在的糖苷酶抑制剂
    摘要:
    据报道,首次全合成天然存在的亚氨基糖,(+)-腺嘌呤,由加纳醛的 (+)-对映异构体分 14 个步骤完成。该策略基于对映体纯的反式-6-乙基-2-羟甲基-1,2,5,6-四氢吡啶的制备和功能化。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
    DOI:
    10.1002/ejoc.200700459
点击查看最新优质反应信息

文献信息

  • First Total Synthesis of (+)-Adenophorine, a Naturally Occurring Inhibitor of Glycosidases
    作者:Morwenna S. M. Pearson、Michel Evain、Monique Mathé-Allainmat、Jacques Lebreton
    DOI:10.1002/ejoc.200700459
    日期:2007.10
    The first total synthesis of a naturally occurring iminosugar, (+)-adenophorine, in 14 steps from the (+)-enantiomer ofGarner's aldehyde, is reported. The strategy is based onthe preparation and functionalization of enantiomericallypure trans-6-ethyl-2-hydroxymethyl-1,2,5,6-tetrahydropyridine. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
    据报道,首次全合成天然存在的亚氨基糖,(+)-腺嘌呤,由加纳醛的 (+)-对映异构体分 14 个步骤完成。该策略基于对映体纯的反式-6-乙基-2-羟甲基-1,2,5,6-四氢吡啶的制备和功能化。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
  • First Total Synthesis of 1-<i>O</i>-β-<scp>d</scp>-Glucopyranosyl-5-deoxyadenophorine and Its Aglycon Congener:  Determination of the Absolute Configuration
    作者:François-Xavier Felpin、Kamal Boubekeur、Jacques Lebreton
    DOI:10.1021/jo035522m
    日期:2004.3.1
    The first total synthesis of the potent glycosidase inhibitors 1-O-β-d-glucopyranosyl-5-deoxyadenophorine and its aglycon congener is described in respectively 13 steps (9% overall yield) and 9 steps (29% overall yield) from (R)-Garner aldehyde. The synthesis takes advantage of several key reactions including a diastereoselective allylation of a chiral imine, a stereoselective epoxidation, and a glycoside
    有效的糖苷酶抑制剂1- O - β - d-吡喃葡萄糖基-5-脱氧腺苷及其配子同源物的第一个总合成分别由(R)-加纳醛。该合成利用了几个关键反应,包括手性亚胺的非对映选择性烯丙基化,立体选择性环氧化和糖苷偶联。此外,这项研究明确地确定了天然产物的绝对构型。
查看更多

同类化合物

7-亚乙基-环戊二烯并(b)环氧乙烷并(c)吡啶六氢衍生物. 4-甲基-3-氧杂-6-氮杂三环[3.2.0.02,4]庚烷-7-酮 3-氧杂-6-氮杂三环[3.2.2.02,4]壬烷(8CI,9CI) 3-氧杂-1-氮杂三环[5.2.0.02,4]壬烷 2-氧杂-6-氮杂三环[4.3.1.01,3]癸烷 (1S,2R,4S,5R)-3-氧杂-6-氮杂三环[3.2.1.02,4]辛烷-7-酮 (5R,7S,8R,8aR)-5-dodecyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one (2S,2R,4S,5R,6S)-(+)-2-{2-[2-[1,3]-dioxolan-2-yl-ethyl]-6-methyl-4,5-epoxy-3,6-dihydro-2H-pyridin-1-yl}-2-phenylethanol (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one dihydroabikoviromycin (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1aR,6aS,7R,7aS)-7-(t-butyldimethylsilyloxy)tetrahydro-1aH-oxazolo[3,4-a]oxireno[2,3-d]pyridin-4(2H)-one 11-formyl-(1rN,2tH,4tH,6cN,7tH,9tH)-3,8-dioxa-11-aza-tetracyclo[4.4.1.02,4.07,9]undecane 7-Oxa-2-azabicyclo[4.1.0]heptane (1S,6S)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-Oxa-10-azatricyclo[4.3.1.0~2,4~]decane (3S,5R,6R,7R)-6-hydroxy-4,9-dioxa-1-azatricyclo[5.3.0.03,5]decan-10-one (1RS,2SR,4RS,5SR)-3-oxa-6-azatricyclo[3.2.1.02,4]octan-7-one (1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-(methanesulfonyl)-7-oxa-3-azabicyclo[4.1.0]heptane 3α,4α-epoxy-2-piperidone (+)-tedanalactam 5-amino-1,2-anhydro-5-deoxy-D-lyxono-1,4-lactame (1R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6R)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6S)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-(cyclopropylmethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-ethyl-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methylpropyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methoxyethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,6S)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6S)-7-oxa-2-azabicyclo[4.1.0]heptane (1S,6R)-7-oxa-2-azabicyclo[4.1.0]heptane (1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2S,4R,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2R,4S,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1S,2S,4S,5R)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2S,4R,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1R,6R)-1-methyl-3-propyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2R,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,6S)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane